Skorpios Trust

STOK

Skorpios Trust serves as 10% Owner at Stoke Therapeutics, Inc. (STOK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$68.98M

Net Position

Net Seller

$68.98M

Companies Traded

STOK

Active Period

Apr 2024 – Sep 2024

2 total trades

Most Recent

Sell STOK

Sep 23, 2024 · $27.22M

Skorpios Trust's Insider Trading at Stoke Therapeutics, Inc. (STOK)

Buys

0 · $0.00

Sells

2 · $68.98M

Total Shares Bought

Total Shares Sold

5,537,500

STOK Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 23, 2024	Sell	1,937,500	$14.05	$27.22M	8,906,181
Apr 18, 2024	Sell	3,600,000	$11.60	$41.76M	10,843,681

Related Insiders

Barry Ticho

officer: CHIEF MEDICAL OFFICER

STOKSell · Apr 3, 2026

Jonathan Allan

officer: GENERAL COUNSEL & CORP SEC

STOKSell · Mar 24, 2026

Thomas Leggett

officer: Chief Financial Officer

STOKSell · Mar 19, 2026

Jason Hoitt

officer: Chief Patient Officer

STOKSell · Mar 19, 2026

LEVIN ARTHUR A

director

STOKSell · Mar 17, 2026

Adrian R. Krainer

Director

STOKSell · Mar 12, 2026

TZIANABOS ARTHUR

director, officer: Interim Executive Chair

STOKSell · Mar 12, 2026

Edward M. MD Kaye

Director

STOKSell · Dec 8, 2025

Explore More Insider Trading Data

STOK Insider Trading Activity

View all insider trades at Stoke Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity